ER-alpha 36, a Variant of ER-alpha, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways

No Thumbnail Available

Authors

Lin, Sheng-Li
Yan, Li-Ying
Zhang, Xin-Tian
Yuan, Ju
Li, Mo
Qiao, Jie
Wang, Zhao-Yi
Sun, Qing-Yuan

Issue Date

2010

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways

Abstract

Description

Citation

Lin, Sheng-Li; Yan, Li-Ying; Zhang, Xin-Tian; Yuan, Ju; Li, Mo; Qiao, Jie; Wang, Zhao-Yi; Sun, Qing-Yuan. ER-alpha 36, a Variant of ER-alpha, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways. Plos One. 2010, FEB 2. 5(2):e9013-e9013.

Publisher

License

Journal

Volume

Issue

URI

http://hdl.handle.net/10504/57086

PubMed ID

20126312

DOI

ISSN

1932-6203
1932-6203

EISSN

Collections

Faculty Bibliography Database